Unlocking the long-term potential of clinical trial data
The covid-19 pandemic brought significant disruption to the clinical trial strategy, resulting in a reduced amount of clinical research and a higher concern for safety, integrity and management of data. This has led to an accelerated shift to new innovations, like AI and machine learning, and remote functioning models. Clinical data has proven to be one of the key assets in consolidating life science future, but how can we unlock the potential of this clinical trial data in the long term, and what expectations are there of clinical trial stakeholders in how clinical research should be run?
Join our discussion with a panel of clinical trial experts as we discuss new opportunities for data management in overall Clinical trial digital transformation. We will showcase some innovative steps organisations have already taken, and how these have allowed them to create and develop a stronger clinical trial environment.
• Current challenges in managing, collecting and archiving clinical trial data in an uncertain environment
• Lessons learned during the pandemic and from past clinical trial digital transformation experiences
• Upcoming opportunities in using innovative technologies for clinical research
• How e-TMF can accelerate your inspection readiness and long term data strategy
• ROI your organisation can achieve with developing a strong clinical trial data strategy
Speakers:
Chris Sigley, CEO, Arkivum
Dr. David Brindley, Managing Partner, Biolacuna
Cindy Dukes, Biolacuna
Matthew Addis, CTO and Co-founder, Arkivum
Russell Joyce, Director and Principal Consultant, Heath Barrowcliff Consulting
